Arbutus Biopharma Corporation Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
WHITEFORT CAPITAL MANAGEMENT, LP | 02/14/2025 | 13.24 M | $43.30 M | 2.91% | 7.01% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 12.94 M | $42.31 M | 5.88% | 6.85% |
VANGUARD GROUP INC | 02/11/2025 | 8.98 M | $29.37 M | 0.70% | 4.75% |
TWO SEAS CAPITAL LP | 02/18/2025 | 8.74 M | $28.58 M | 4.22% | 4.62% |
STATE STREET CORP | 02/14/2025 | 5.03 M | $16.44 M | 14.06% | 2.66% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.48 M | $11.39 M | 0.97% | 1.84% |
BLACKBARN CAPITAL PARTNERS LP | 02/14/2025 | 2.34 M | $7.66 M | 13.08% | 1.24% |
RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 1.68 M | $5.50 M | 0.00% | 0.89% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.65 M | $5.40 M | -43.09% | 0.87% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 1.55 M | $5.08 M | -25.58% | 0.82% |
02/12/2025 | 1.46 M | $4.77 M | 100.00% | 0.77% | |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1.36 M | $5.24 M | -0.72% | 0.72% |
FOURWORLD CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.23 M | $4.01 M | -58.73% | 0.65% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.22 M | $4.00 M | 0.82% | 0.65% |
HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 1.11 M | $3.64 M | 8.01% | 0.59% |
WOODLINE PARTNERS LP | 02/14/2025 | 971,628 | $3.18 M | 45.42% | 0.51% |
JPMORGAN CHASE & CO | 02/12/2025 | 896,258 | $2.93 M | 900.44% | 0.47% |
SABA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 887,993 | $2.90 M | 31.28% | 0.47% |
CORBIN CAPITAL PARTNERS, L.P. | 02/11/2025 | 682,487 | $2.23 M | -20.02% | 0.36% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 531,878 | $1.74 M | -5.09% | 0.28% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 513,302 | $1.68 M | 3.32% | 0.27% |
BANK OF MONTREAL /CAN/ | 02/13/2025 | 455,880 | $1.49 M | 3.54% | 0.24% |
FREESTONE CAPITAL HOLDINGS, LLC | 02/06/2025 | 442,500 | $1.45 M | -0.16% | 0.23% |
KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 420,709 | $1.38 M | 0.19% | 0.22% |
QUINN OPPORTUNITY PARTNERS LLC | 02/13/2025 | 404,879 | $1.32 M | 72.19% | 0.21% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 390,337 | $1.28 M | 129.22% | 0.21% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 353,374 | $1.16 M | 0.23% | 0.19% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 343,028 | $1.12 M | 36.69% | 0.18% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 313,307 | $1.02 M | 0.00% | 0.17% |
BARCLAYS PLC | 02/13/2025 | 298,253 | $975,000 | 9.64% | 0.16% |
SWISS NATIONAL BANK | 02/10/2025 | 276,300 | $903,501 | 0.00% | 0.15% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 247,996 | $810,947 | -19.05% | 0.13% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 244,600 | $799,842 | -34.21% | 0.13% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 202,541 | $662,309 | 100.00% | 0.11% |
RHUMBLINE ADVISERS | 01/30/2025 | 188,598 | $616,706 | 6.03% | 0.10% |
CITIGROUP INC | 02/12/2025 | 187,720 | $613,844 | 72.14% | 0.10% |
SQUAREPOINT OPS LLC | 02/14/2025 | 184,500 | $603,315 | 100.00% | 0.10% |
SQUAREPOINT OPS LLC | 02/14/2025 | 178,099 | $582,384 | 174.81% | 0.09% |
CAPTION MANAGEMENT, LLC | 02/14/2025 | 175,000 | $572,250 | 100.00% | 0.09% |
DEUTSCHE BANK AG\ | 02/14/2025 | 171,766 | $561,675 | 77.90% | 0.09% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 162,277 | $530,646 | -73.50% | 0.09% |
LMR PARTNERS LLP | 02/14/2025 | 158,249 | $517,474 | -19.68% | 0.08% |
CITIGROUP INC | 02/12/2025 | 150,000 | $490,500 | -52.74% | 0.08% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 146,803 | $480,046 | 27.63% | 0.08% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 02/14/2025 | 132,758 | $434,119 | -1.13% | 0.07% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 120,240 | $393,185 | -12.63% | 0.06% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 118,693 | $388,125 | -18.59% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 115,222 | $376,776 | 9.80% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 112,000 | $366,240 | -19.42% | 0.06% |
ROCKEFELLER CAPITAL MANAGEMENT L.P. | 02/13/2025 | 106,615 | $348,631 | 69.23% | 0.06% |
Arbutus Biopharma Corporation institutional Ownership - FAQ's
During the previous two years, 182 institutional investors and hedge funds held shares of Arbutus Biopharma Corporation. The most heavily invested institutionals were:
Whitefort Capital Management, LP: 13.24 M
BlackRock Funding, Inc. /DE: 12.94 M
VANGUARD GROUP INC: 8.98 M
Two Seas Capital LP: 8.74 M
STATE STREET CORP: 5.03 M
GEODE CAPITAL MANAGEMENT, LLC: 3.48 M
54.90% of Arbutus Biopharma Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 115.40 M shares in the last 24 months. This purchase volume represents approximately $377.36 M in transactions.